Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Cert. of designation
Filed Chapter 11
Director departure
Appointed director
Quarterly results
Nuo Therapeutics, Inc. (AURX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/03/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
Docs: "Securities Purchase Agreement"
12/05/2022 8-K Quarterly results
09/30/2022 8-K Shareholder Nominations Pursuant to Exchange Act Rule 14a-11, Other Events  Interactive Data
08/30/2022 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
Docs: "Form of First Warrant",
"Form of Second Warrant",
"Form of Contingent Warrant",
"Common Stock and Warrant Purchase Agreement between the Registrant and Pacific Medical, Inc.",
"NUO THERAPEUTICS PROVIDES CORPORATE AND BUSINESS UPDATE"
06/28/2022 8-K Quarterly results
05/02/2022 8-K Quarterly results
01/04/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "Warrant Modification Agreement"
04/21/2021 8-K Quarterly results
10/06/2020 8-K Quarterly results
04/13/2020 8-K Other Events
03/30/2020 8-K Other Events
12/12/2019 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Convertible Promissory Note Fifth Amendment with Auctus Fund LLC",
"Convertible Promissory Note Fifth Amendment with EMA Financial LLC"
11/20/2019 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "SENIOR SECURED PROMISSORY NOTE",
"COMMON STOCK PURCHASE WARRANT NUO THERAPEUTICS, INC.",
"Form of Security Agreement",
"Nuo Therapeutics, Inc. ____________________________ Note Purchase Agreement ____________________________ Nuo Therapeutics, Inc. Note Purchase Agreement"
08/09/2019 8-K Quarterly results
06/13/2019 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Convertible Promissory Note Third Amendment with Auctus Funds LLC",
"Convertible Promissory Note Third Amendment with EMA Financial, LLC"
05/07/2019 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Convertible Promissory Note Second Amendment with Auctus Funds LLC",
"Convertible Promissory Note Second Amendment with EMA Financial, LLC"
03/22/2019 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Convertible Promissory Note Amendment with Auctus Funds LLC",
"Convertible Promissory Note Amendment with EMA Financial, LLC",
"Nuo Therapeutics Provides Update on Ongoing Interactions with Centers for Medicare & Medicaid Services"
01/15/2019 8-K Regulation FD Disclosure, Financial Statements and Exhibits
01/03/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
10/26/2018 8-K Quarterly results
10/02/2018 8-K Quarterly results
09/21/2018 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "12% Convertible Promissory Note issued to Auctus Fund, LLC",
"12% Convertible Promissory Note issued to EMA Financial, LLC",
"Form of Warrant",
"Securities Purchase Agreement between Nuo Therapeutics, Inc. and Auctus Fund, LLC",
"Securities Purchase Agreement between Nuo Therapeutics, Inc. and EMA Financial, LLC"
09/05/2018 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
Docs: "Certificate of Amendment to Second Amended and Restated Certificate of Incorporation"
08/10/2018 8-K Changes in Registrant's Certifying Accountant, Departure of Directors or Certain Officers; Election of Directors; Appointment...
Docs: "Letter from GBH CPAs, PC to the Securities and Exchange Commission"
06/28/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/30/2018 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Securities Purchase Agreement",
"Amendment No. 1 to Exclusive License and Distribution Agreement"
04/04/2018 8-K Other Events
01/19/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
09/28/2017 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
09/14/2017 8-K Quarterly results
08/14/2017 8-K Quarterly results
07/05/2017 8-K Other Events, Financial Statements and Exhibits
Docs: "Nuo Therapeutics Receives Advisory Opinion Waiver for Medicare Part B Co-Payments for Patients in Aurix CED Clinical Studies GAITHERSBURG, Md., July 05, 2017 -- Nuo Therapeutics, Inc. announced today that the Office of Inspector General of Department of Health and Human Services has issued an advisory opinion allowing the waiver of co-payments required from Medicare beneficiaries participating in the Aurix Coverage with Evidence Development clinical studies based on an individualized assessment of financial ability. The opinion was issued in response to a request submitted by Nuo and a co-requesting hospital facility. The advisory opinion request asked OIG to indicate that the hospital facility would not be subject to civil or administrative penalties under the Social Security Act and ass..."
06/12/2017 8-K Form 8-K - Current report
05/08/2017 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy